A protocol for analyzing hepatitis C virus replication

Area of Science:

• Virology
• Hepatology
• Molecular Biology

Background:

• Hepatitis C Virus (HCV) infects 3% of the global population, leading to severe liver diseases like cirrhosis and cancer.
• Existing treatments for HCV are suboptimal, with significant side effects and no available vaccine, necessitating further research.
• An effective HCV cell culture system is essential for understanding viral replication dynamics and developing interventions.

Purpose of the Study:

• To present and validate a comprehensive set of virological assays for characterizing the Hepatitis C Virus replication cycle.
• To establish a functional cell culture model for studying HCV infection and viral particle production.
• To provide tools for assessing viral replication levels and infectivity crucial for therapeutic and vaccine development.

Main Methods:

• Utilized a wild-type intragenotype 2a chimeric virus (FNX-HCV) and a Renilla luciferase reporter virus (FNX-Rluc) in a human hepatoma cell line (Huh-7).
• Assessed viral RNA replication via quantitative RT-PCR and detection of double-stranded RNA.
• Verified viral protein expression (NS3, NS5A) using Western blot and immunofluorescence; measured infectious viral particles and luciferase activity.

Main Results:

• Demonstrated successful transfection and replication of HCV RNA in Huh-7 cells.
• Confirmed the release of infectious HCV particles into cell culture supernatants.
• Quantified viral replication levels and infectivity using luciferase reporter assays.

Conclusions:

• The presented virological assays effectively characterize multiple stages of the HCV replication cycle in a cell culture system.
• This methodology supports the study of HCV pathogenesis and the evaluation of novel antiviral strategies and vaccine candidates.
• The established system provides a valuable platform for advancing Hepatitis C Virus research.